We are live on ! Find out more
PHP

Parkman Healthcare Partners Portfolio holdings

AUM $970M
1-Year Est. Return 79.46%
This Fund
S&P 500
This Quarter Est. Return
+14.73%
1 Year Est. Return
+79.46%
3 Year Est. Return
+312.89%
5 Year Est. Return
+648.59%
10 Year Est. Return
–
AUM
$352M
AUM Growth
+$80.2M
Cap. Flow
+$76.6M
Cap. Flow %
21.79%
Top 10 Hldgs %
34.86%
Holding
100
New
24
Increased
44
Reduced
21
Closed
11

Top Buys

Rank Stock Value
1
BSX icon
Boston Scientific
BSX
+$14M
2
LLY icon
Eli Lilly
LLY
+$11.2M
3
EW icon
Edwards Lifesciences
EW
+$7.88M
4
HAE icon
Haemonetics
HAE
+$6.52M
5
CVS icon
CVS Health
CVS
+$6.34M

Top Sells

Rank Stock Value
1
IRTC icon
iRhythm Holdings
IRTC
+$7.01M
2
ALT icon
Altimmune
ALT
+$6.55M
3
AVTR icon
Avantor
AVTR
+$5.36M
4
MASS icon
908 Devices
MASS
+$3.07M
5
XENE icon
Xenon Pharmaceuticals
XENE
+$2.59M

Sector Composition

Rank Sector Weight
1 Healthcare 96.37%
2 Industrials 1.47%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
DAWN
26
DELISTED
Day One Biopharmaceuticals
DAWN
$4.25M 1.21%
212,191
+97,441
+85% +$2.07M
PRCT icon
27
Procept Biorobotics
PRCT
$1.22B
$4.2M 1.19%
101,201
+6,701
+7% +$267K
PODD icon
28
Insulet
PODD
$10.1B
$3.91M 1.11%
17,054
+3,165
+23% +$793K
STRO icon
29
Sutro Biopharma
STRO
$353M
$3.81M 1.08%
68,734
+50,282
+273% +$2.98M
TMO icon
30
Thermo Fisher Scientific
TMO
$223B
$3.8M 1.08%
+7,500
New +$4.2M
ANIP icon
31
ANI Pharmaceuticals
ANIP
$1.73B
$3.79M 1.08%
117,941
+9,382
+9% +$321K
KROS icon
32
Keros Therapeutics
KROS
$222M
$3.76M 1.07%
99,927
+52,139
+109% +$1.81M
ACRS icon
33
Aclaris Therapeutics
ACRS
$860M
$3.68M 1.05%
233,626
-71,217
-23% -$1.12M
BMRN icon
34
BioMarin Pharmaceuticals
BMRN
$13.6B
$3.64M 1.04%
+42,961
New +$3.83M
APEN
35
DELISTED
Apollo Endosurgery, Inc.
APEN
$3.62M 1.03%
657,690
+7,690
+1% +$42.6K
RCUS icon
36
Arcus Biosciences
RCUS
$3.69B
$3.61M 1.03%
137,894
-33,320
-19% -$881K
COGT icon
37
Cogent Biosciences
COGT
$6.76B
$3.53M 1%
236,697
-52,053
-18% -$713K
VRNA
38
DELISTED
Verona Pharma
VRNA
$3.3M 0.94%
+323,273
New +$2.72M
CTLT
39
DELISTED
CATALENT, INC.
CTLT
$3.28M 0.93%
45,304
-22,314
-33% -$2.22M
DXCM icon
40
DexCom
DXCM
$34.3B
$3.25M 0.92%
40,358
+5,524
+16% +$468K
IRTC icon
41
iRhythm Holdings
IRTC
$4.13B
$3.19M 0.91%
25,458
-48,543
-66% -$7.01M
NSTG
42
DELISTED
NanoString Technologies, Inc.
NSTG
$3.1M 0.88%
+242,600
New +$3.37M
SDGR icon
43
Schrodinger
SDGR
$1.39B
$3.09M 0.88%
123,679
+1,454
+1% +$42.7K
SUPN icon
44
Supernus Pharmaceuticals
SUPN
$2.78B
$3.04M 0.86%
89,709
+1,051
+1% +$34.2K
MNKD icon
45
MannKind Corp
MNKD
$1.24B
$2.86M 0.81%
924,979
+160,165
+21% +$604K
IMGO
46
DELISTED
Imago BioSciences, Inc. Common stock
IMGO
$2.85M 0.81%
189,193
+41,806
+28% +$678K
ISRG icon
47
Intuitive Surgical
ISRG
$142B
$2.81M 0.8%
+15,000
New +$3.22M
COO icon
48
Cooper Companies
COO
$15B
$2.8M 0.8%
42,488
+488
+1% +$37.4K
LNTH icon
49
Lantheus
LNTH
$6.57B
$2.79M 0.79%
39,682
+18,255
+85% +$1.38M
KRTX
50
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
$2.7M 0.77%
+12,000
New +$2.43M
1
2
3 4

Similar funds

LOIM
Liberty One Investment Management Libertyville, Illinois $970M AUM 12.15% 1-Year Est. Return
MGCM
Mane Global Capital Management New York $971M AUM 58.5% 1-Year Est. Return
JWM
Jackson Wealth Management Lake Mary, Florida $972M AUM 22.58% 1-Year Est. Return
WAM
WNY Asset Management Williamsville, New York $967M AUM
GHC
Graham Holdings Company Arlington, Virginia $967M AUM 15.12% 1-Year Est. Return
SAM
Stansberry Asset Management Westlake, Texas $973M AUM 21.39% 1-Year Est. Return
TCCM
Two Creeks Capital Management New York $974M AUM 2.54% 1-Year Est. Return
UIC
Uniplan Investment Counsel Milwaukee, Wisconsin $974M AUM 21.37% 1-Year Est. Return

Parkman Healthcare Partners's Q3 2022 Portfolio in Review

As of Q3 2022, Parkman Healthcare Partners held 100 positions worth $352M, up 30% from $272M the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Parkman Healthcare Partners deployed $76.6M of net new capital in Q3 2022, opening 24 new positions and adding to 44 existing holdings. Its largest new stake was Boston Scientific: 347,787 shares worth $13.5M.

By sector, the portfolio is most concentrated in Healthcare at 96% of assets, down from 96% a quarter earlier, followed by Industrials.

On the sell side, the largest reduction was iRhythm Holdings, an estimated $7.01M trimmed.

  • Parkman Healthcare Partners's largest Q3 2022 buy was Boston Scientific: 347,787 shares worth $13.5M.
  • Parkman Healthcare Partners added most to Haemonetics in Q3 2022, an estimated $6.52M increase.
  • Parkman Healthcare Partners's biggest Q3 2022 reduction was iRhythm Holdings, cutting an estimated $7.01M.
  • Parkman Healthcare Partners fully exited Altimmune in Q3 2022, selling an estimated $6.55M.
  • Parkman Healthcare Partners's ten largest holdings make up 35% of its $352M portfolio in Q3 2022.
  • Parkman Healthcare Partners opened 24 new positions and closed 11 in Q3 2022.
  • Parkman Healthcare Partners's portfolio value rose 30% quarter-over-quarter to $352M.

Based on Parkman Healthcare Partners's 13F filing for Q3 2022, filed 14 Nov 2022.